SCHEMBL5043836

SCHEMBL5043836

COc1ccc(-c2nc(-c3cc(OC(=O)NN4CCCCC4)c(C)n3CC3CCCCC3)cs2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 3/20 0.46
CDC25B P30305 3/20 0.46
CDC25C P30307 3/20 0.46
DUSP3 P51452 3/20 0.46
KCNQ1 P51787 14/20 0.42
NTMT1 Q9BV86 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
OXTR P30559 1/20 0.39
AVPR1A P37288 1/20 0.39
AVPR1B P47901 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043910 0.89 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3SMN1; SMN2
SCHEMBL5039914 0.89 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5140692 0.89 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3SMN1; SMN2
SCHEMBL5039564 0.88 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3MEN1
SCHEMBL5048642 0.88 CDC25A (0.44) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5043827 0.88 CDC25A (0.47) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5047022 0.87 CDC25A (0.46) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5046954 0.86 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5045038 0.86 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3KCNQ1
SCHEMBL5043889 0.86 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed